ArticleStem cell research & therapy2020

Tumor necrosis factor α in aGVHD patients contributed to the impairment of recipient bone marrow MSC stemness and deficiency of their hematopoiesis-promotion capacity.

Li Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.